Variant report

Variant	esv3343656
Chromosome Location	chr3:134368312-134371210
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:150)
CpG islands
(count:916)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:150 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:134369126-134370111	H1-hESC	embryonic stem cell:	n/a	chr3:134369312-134369326
2	CEBPB	chr3:134371083-134371413	IMR90	lung:	n/a	n/a
3	CHD2	chr3:134369871-134370041	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr3:134369960-134370110	HCM	heart:	n/a	n/a
5	CTCF	chr3:134369720-134369870	HAc	cerebellar:	n/a	n/a
6	CTCF	chr3:134369467-134369566	NHEK	skin:	n/a	n/a
7	CTCF	chr3:134370060-134370210	HRE	kidney:	n/a	n/a
8	CTCF	chr3:134369840-134369990	AG10803	skin:	n/a	n/a
9	CTCF	chr3:134369860-134370010	HA-sp	spinal cord:	n/a	n/a
10	CTCF	chr3:134369712-134370078	IMR90	lung:	n/a	n/a
11	CTCF	chr3:134369864-134369994	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr3:134369820-134369970	HRPEpiC	eye:	n/a	n/a
13	CTCF	chr3:134369560-134369710	BJ	skin:	n/a	chr3:134369586-134369599 chr3:134369584-134369602 chr3:134369586-134369599
14	CTCF	chr3:134369820-134369970	AG04449	skin:	n/a	n/a
15	CTCF	chr3:134370320-134370470	BJ	skin:	n/a	n/a
16	CTCF	chr3:134369726-134370076	Fibrobl	skin:	n/a	n/a
17	CTCF	chr3:134369880-134370030	BE2_C	brain:	n/a	n/a
18	CTCF	chr3:134369480-134369630	AG10803	skin:	n/a	chr3:134369586-134369599 chr3:134369584-134369602 chr3:134369586-134369599
19	CTCF	chr3:134369880-134370030	HPAF	blood vessel:	n/a	n/a
20	CTCF	chr3:134369820-134369970	AG09309	skin:	n/a	n/a
21	CTCF	chr3:134369965-134369971	GM19240	blood:	n/a	n/a
22	CTCF	chr3:134369912-134369943	GM12878	blood:	n/a	n/a
23	CTCF	chr3:134370480-134370630	SK-N-SH_RA	brain:	n/a	n/a
24	CTCF	chr3:134369820-134369970	NHDF-neo	bronchial:	n/a	n/a
25	CTCF	chr3:134369840-134369990	WERI-Rb-1	eye:	n/a	n/a
26	CTCF	chr3:134369840-134369990	HVMF	connective:	n/a	n/a
27	CTCF	chr3:134370240-134370390	BE2_C	brain:	n/a	n/a
28	CTCF	chr3:134369880-134370030	HUVEC	blood vessel:	n/a	n/a
29	CTCF	chr3:134369822-134369994	Kidney_OC	kidney:	n/a	n/a
30	CTCF	chr3:134369800-134369950	A549	lung:	n/a	n/a
31	CTCF	chr3:134370020-134370170	NHDF-neo	bronchial:	n/a	n/a
32	CTCF	chr3:134369840-134369990	HMEC	breast:	n/a	n/a
33	CTCF	chr3:134369780-134369930	HMEC	breast:	n/a	n/a
34	CTCF	chr3:134369780-134369930	HFF-Myc	foreskin:	n/a	n/a
35	CTCF	chr3:134369840-134369990	NB4	blood:	n/a	n/a
36	CTCF	chr3:134369531-134369667	SK-N-SH_RA	brain:	n/a	chr3:134369586-134369599 chr3:134369584-134369602 chr3:134369586-134369599
37	CTCF	chr3:134369760-134369910	NHEK	skin:	n/a	n/a
38	CTCF	chr3:134369800-134369950	HBMEC	blood vessel:	n/a	n/a
39	CTCF	chr3:134369840-134369990	SAEC	small airway:	n/a	n/a
40	CTCF	chr3:134369820-134369970	AG09319	gingival:	n/a	n/a
41	CTCF	chr3:134369800-134369950	HRE	kidney:	n/a	n/a
42	CTCF	chr3:134369880-134369944	LNCaP	prostate:	n/a	n/a
43	CTCF	chr3:134369843-134370017	HepG2	liver:	n/a	n/a
44	CTCF	chr3:134369580-134369730	SK-N-SH_RA	brain:	n/a	chr3:134369586-134369599 chr3:134369584-134369602 chr3:134369586-134369599
45	CTCF	chr3:134369980-134370130	RPTEC	kidney:	n/a	n/a
46	CTCF	chr3:134369789-134369997	LNCaP	prostate:	n/a	n/a
47	CTCF	chr3:134369800-134369950	BE2_C	brain:	n/a	n/a
48	CTCF	chr3:134369524-134369777	H1-hESC	embryonic stem cell:	n/a	chr3:134369586-134369599 chr3:134369584-134369602 chr3:134369586-134369599
49	CTCF	chr3:134369840-134369990	AoAF	blood vessel:	n/a	n/a
50	CTCF	chr3:134369860-134370010	AG10803	skin:	n/a	n/a

(count:916 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:134370147-134370197	MCF-7	breast:	n/a
2	chr3:134370147-134370197	MCF-7	breast:	n/a
3	chr3:134370662-134370712	GM06990	blood:	n/a
4	chr3:134369339-134369389	RPTEC	kidney:	n/a
5	chr3:134370555-134370605	HUVEC	blood vessel:	n/a
6	chr3:134370182-134370232	NHBE	bronchial:	n/a
7	chr3:134370182-134370232	NB4	blood:	n/a
8	chr3:134370015-134370065	GM12878	blood:	n/a
9	chr3:134369828-134369878	NHDF-neo	bronchial:	n/a
10	chr3:134370015-134370065	HEEpiC	esophagus:	n/a
11	chr3:134369465-134369515	HEEpiC	esophagus:	n/a
12	chr3:134370182-134370232	BJ	skin:	n/a
13	chr3:134370182-134370232	AG04450	lung:	fetal
14	chr3:134370182-134370232	PrEC	prostate:	n/a
15	chr3:134369939-134369989	MCF10A-Er-Src	breast:	n/a
16	chr3:134370241-134370291	SAEC	small airway:	n/a
17	chr3:134370555-134370605	AG04449	skin:	fetal
18	chr3:134370555-134370605	IMR90	lung:	fetal
19	chr3:134370555-134370605	A549	lung:	n/a
20	chr3:134369828-134369878	HCM	heart:	n/a
21	chr3:134370015-134370065	LNCaP	prostate:	n/a
22	chr3:134369987-134370037	MCF-7	breast:	n/a
23	chr3:134369974-134370024	HEEpiC	esophagus:	n/a
24	chr3:134370147-134370197	NT2-D1	testis:	n/a
25	chr3:134369339-134369389	SK-N-SH	brain:	n/a
26	chr3:134369339-134369389	SKMC	muscle:	n/a
27	chr3:134369974-134370024	HRPEpiC	eye:	n/a
28	chr3:134369987-134370037	HNPCEpiC	eye:	n/a
29	chr3:134370241-134370291	NH-A	brain:	n/a
30	chr3:134369661-134369711	GM12892	blood:	n/a
31	chr3:134370662-134370712	MCF-7	breast:	n/a
32	chr3:134370046-134370096	NT2-D1	testis:	n/a
33	chr3:134369939-134369989	NH-A	brain:	n/a
34	chr3:134369939-134369989	BE2_C	brain:	n/a
35	chr3:134369919-134369969	MCF10A-Er-Src	breast:	n/a
36	chr3:134370555-134370605	LNCaP	prostate:	n/a
37	chr3:134370182-134370232	HNPCEpiC	eye:	n/a
38	chr3:134370182-134370232	Caco-2	colon:	n/a
39	chr3:134370147-134370197	HCT-116	colon:	n/a
40	chr3:134370555-134370605	ProgFib	skin:	n/a
41	chr3:134369919-134369969	PrEC	prostate:	n/a
42	chr3:134370015-134370065	IMR90	lung:	fetal
43	chr3:134370241-134370291	MCF-7	breast:	n/a
44	chr3:134370662-134370712	HEK293	kidney:	embryo
45	chr3:134369919-134369969	Caco-2	colon:	n/a
46	chr3:134370555-134370605	AG04450	lung:	fetal
47	chr3:134370046-134370096	AG09309	skin:	n/a
48	chr3:134370147-134370197	RPTEC	kidney:	n/a
49	chr3:134369919-134369969	HAEpiC	amniotic membrane:	n/a
50	chr3:134369465-134369515	IMR90	lung:	fetal

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr3:134370814..134375265-chr3:134381984..134385819,4	MCF-7	breast:

No data

Variant related genes	Relation type
KY	TF binding region
KY	CpG island

Extended variants
information (count: 114 )
Associated
traits (count: 53 )

Variant overlapped rSNPs/rCNVs (count:114 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs529587598	chr3:134368341-134368342	Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs549242483	chr3:134368347-134368348	Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs569140969	chr3:134368535-134368536	Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs376644015	chr3:134368564-134368565	Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
5	rs371573653	chr3:134368626-134368627	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs10212595	chr3:134368634-134368635	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs534640306	chr3:134368663-134368664	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs570533346	chr3:134368677-134368678	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs368466042	chr3:134368740-134368741	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs370448906	chr3:134368756-134368757	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs552316420	chr3:134368811-134368812	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs187664091	chr3:134368814-134368815	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
13	rs572873079	chr3:134368869-134368870	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
14	rs535777785	chr3:134368917-134368918	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
15	rs138707471	chr3:134368936-134368937	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs575419583	chr3:134368964-134368965	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs577827503	chr3:134368971-134368972	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs193217647	chr3:134368982-134368983	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs564085166	chr3:134369012-134369013	Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs578078269	chr3:134369046-134369047	Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs540322872	chr3:134369061-134369062	Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs566064567	chr3:134369130-134369131	Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs560139723	chr3:134369134-134369135	Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs374819008	chr3:134369178-134369179	Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs529231988	chr3:134369198-134369199	Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs79480766	chr3:134369208-134369209	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs185684142	chr3:134369210-134369211	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs34002900	chr3:134369216-134369217	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs531865303	chr3:134369248-134369249	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs551963191	chr3:134369264-134369265	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs563229912	chr3:134369268-134369269	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs76488157	chr3:134369278-134369279	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs533096447	chr3:134369291-134369292	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs373319390	chr3:134369292-134369293	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs115209896	chr3:134369330-134369331	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs371562261	chr3:134369353-134369354	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs535464351	chr3:134369372-134369373	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs575459975	chr3:134369381-134369382	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs1868164	chr3:134369420-134369421	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs537740525	chr3:134369435-134369436	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs7431731	chr3:134369470-134369471	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs568730362	chr3:134369502-134369503	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs190153815	chr3:134369558-134369559	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs577738634	chr3:134369564-134369565	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs537684204	chr3:134369611-134369612	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs369325607	chr3:134369621-134369622	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs368269760	chr3:134369657-134369658	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs573771058	chr3:134369692-134369693	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs373172556	chr3:134369693-134369694	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs376148670	chr3:134369698-134369699	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:53)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
microdeletion syndrome	22180640	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Multiple myeloma	17550852	CNVD
Basal cell lymphoma	21115979	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	18645599	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Hepatocellular carcinoma	16750200	CNVD
Intracranial aneurysm	16715129	CNVD
Lung cancer	16740712	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Myelofibrosis	22110671	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	22522925	CNVD
Developmental delay	21147756	CNVD

Chromatin state (count:354 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:134358200-134368600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
2	chr3:134358400-134368600	Weak transcription	Brain Anterior Caudate	brain
3	chr3:134358400-134368600	Weak transcription	Brain Hippocampus Middle	brain
4	chr3:134358400-134368600	Weak transcription	Brain Inferior Temporal Lobe	brain
5	chr3:134358600-134368600	Weak transcription	Brain Substantia Nigra	brain
6	chr3:134361600-134369600	Weak transcription	Pancreas	Pancrea
7	chr3:134362200-134368800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr3:134363400-134369200	Weak transcription	Adipose Nuclei	Adipose
9	chr3:134363800-134369400	Weak transcription	Ovary	ovary
10	chr3:134364400-134368600	Weak transcription	Rectal Smooth Muscle	rectum
11	chr3:134364400-134369000	Weak transcription	Colon Smooth Muscle	Colon
12	chr3:134364400-134369000	Weak transcription	Duodenum Smooth Muscle	Duodenum
13	chr3:134364400-134369200	Weak transcription	Brain Cingulate Gyrus	brain
14	chr3:134364400-134369200	Weak transcription	Spleen	Spleen
15	chr3:134364400-134369400	Weak transcription	HSMMtube	muscle
16	chr3:134365000-134369400	Weak transcription	Right Atrium	heart
17	chr3:134367000-134369000	Enhancers	Psoas Muscle	Psoas
18	chr3:134367000-134369800	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
19	chr3:134367200-134368400	Weak transcription	Left Ventricle	heart
20	chr3:134367400-134368600	Enhancers	Skeletal Muscle Male	skeletal muscle
21	chr3:134367400-134368600	Weak transcription	Osteobl	bone
22	chr3:134367600-134368400	Active TSS	Fetal Muscle Trunk	muscle
23	chr3:134367600-134368600	Weak transcription	Right Ventricle	heart
24	chr3:134367800-134369200	Enhancers	Breast Myoepithelial Primary Cells	Breast
25	chr3:134368200-134368400	Bivalent Enhancer	Fetal Muscle Leg	muscle
26	chr3:134368200-134368600	Enhancers	Brain Angular Gyrus	brain
27	chr3:134368200-134368600	Enhancers	Fetal Heart	heart
28	chr3:134368200-134371200	Flanking Active TSS	Stomach Smooth Muscle	stomach
29	chr3:134368400-134368600	Flanking Active TSS	Fetal Muscle Trunk	muscle
30	chr3:134368400-134369000	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
31	chr3:134368400-134369000	Enhancers	Left Ventricle	heart
32	chr3:134368400-134371800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
33	chr3:134368600-134368800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr3:134368600-134368800	Flanking Active TSS	Brain Angular Gyrus	brain
35	chr3:134368600-134368800	Enhancers	Brain Anterior Caudate	brain
36	chr3:134368600-134368800	Enhancers	Brain Hippocampus Middle	brain
37	chr3:134368600-134368800	Enhancers	Brain Inferior Temporal Lobe	brain
38	chr3:134368600-134368800	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
39	chr3:134368600-134368800	Flanking Active TSS	Brain Substantia Nigra	brain
40	chr3:134368600-134368800	Active TSS	Osteobl	bone
41	chr3:134368600-134369000	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
42	chr3:134368600-134369200	Enhancers	Right Ventricle	heart
43	chr3:134368600-134369400	Flanking Active TSS	Fetal Heart	heart
44	chr3:134368600-134369600	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
45	chr3:134368600-134370200	Active TSS	Rectal Smooth Muscle	rectum
46	chr3:134368800-134369000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr3:134368800-134369000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr3:134368800-134369000	Weak transcription	Brain Anterior Caudate	brain
49	chr3:134368800-134369000	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
50	chr3:134368800-134369000	Enhancers	NHDF-Ad	bronchial

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links